Dec 04, 2019 / 03:15PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD
Okay. We'll get started. Thanks, everyone, for joining us this morning. I'm Vijay Kumar, the device and life science tools analyst at Evercore. Very happy to have with us Baxter, representing the company, we have Jay Saccaro, the CFO; and from the IR team, we have Clare Trachtman. Thank you, guys, for coming.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MDMaybe Jay, this has been a little bit of an odd year for Baxter. When you look at the last few years, the focus always was on operational excellence. Phenomenal job that the company has done, executing on the margin front. And I feel like the 3Q with the accounting audit, I know you're limited in what you can or cannot say on that front.
But I think on the call, 3Q call, investors were trying on their ability to deploy capital as being tied to the accounting audit. And given you just did the Seprafilm acquisition, maybe you just provide some context on
Trustpilot
